期刊文献+

银屑病与非酒精性脂肪性肝病相关性研究进展

Update of the relation between psoriasis and non-alcoholic fatty liver disease
下载PDF
导出
摘要 研究报道银屑病和非酒精性脂肪性肝病(NAFLD)的发病机制中有共同参与的炎症及细胞因子,银屑病可增加NAFLD的发病风险。胰岛素抵抗、TNF-α及脂肪因子已被证实在银屑病合并NAFLD的发病中具有重要作用。本文对银屑病与非酒精性脂肪性肝病相关性研究进展进行了综述。 The pathogenesis of both psoriasis and non-alcoholic fatty liver disease(NAFLD)is involved in the same inflammatory cytokines and psoriasis can increase the risk of NAFLD.The insulin resistance,TNF-αand adipokines play important roles in the onset of psoriasis complicated with NAFLD.The update of the relationship between psoriasis and non-alcoholic fatty liver disease is reviewed.
作者 李颖 张晓艳
出处 《中国麻风皮肤病杂志》 2019年第2期124-127,共4页 China Journal of Leprosy and Skin Diseases
关键词 银屑病 非酒精性脂肪性肝病 胰岛素抵抗 脂肪因子 psoriasis non-alcoholic fatty liver disease insulin resistance adipokine
  • 相关文献

参考文献4

二级参考文献278

  • 1Griffiths CE, Barker JN. Pathogenesis and clinical features ofpsoriasis. Lancet 2007; 370: 263-271 [PMID: 17658397]. 被引量:1
  • 2Ganzetti G, Campanati A, Scocco V, Brugia M, Tocchini M,Liberati G, Giuliodori K, Brisigotti V, Offidani A. The potentialeffect of the tumour necrosis factor-α inhibitors on vitamin D statusin psoriatic patients. Acta Derm Venereol 2014; 94: 715-717 [PMID:24789007 DOI: 10.2340/00015555-1801]. 被引量:1
  • 3Boehncke WH, Boehncke S. More than skin-deep: the manydimensions of the psoriatic disease. Swiss Med Wkly 2014; 144:w13968 [PMID: 24764145 DOI: 10.4414/smw.2014.13968,]. 被引量:1
  • 4Esposito K, Giugliano D. The metabolic syndrome andinflammation: association or causation- Nutr Metab Cardiovasc Dis2004; 14: 228-232 [PMID: 15673055]. 被引量:1
  • 5McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis.J Clin Gastroenterol 2006; 40 Suppl 1: S17-S29 [PMID: 16540762]. 被引量:1
  • 6Ni C, Chiu MW. Psoriasis and comorbidities: links and risks. ClinCosmet Investig Dermatol 2014; 7: 119-132 [PMID: 24790463DOI: 10.2147/CCID.S44843,]. 被引量:1
  • 7Kotronen A, Yki-J-rvinen H. Fatty liver: a novel component ofthe metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28:27-38 [PMID: 17690317]. 被引量:1
  • 8Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, HortonJD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepaticsteatosis in an urban population in the United States: impact ofethnicity. Hepatology 2004; 40: 1387-1395 [PMID: 15565570]. 被引量:1
  • 9Papatheodoridis GV, Goulis J, Christodoulou D, ManolakopoulosS, Raptopoulou M, Andrioti E, Alexandropoulos N, Savvidou S,Papachristou A, Zervou E, Seferiadis K, Kousidou P, VogiatzakisE, Tsianos E. High prevalence of elevated liver enzymes in blooddonors: associations with male gender and central adiposity. Eur JGastroenterol Hepatol 2007; 19: 281-287 [PMID: 17353691]. 被引量:1
  • 10Hamaguchi M, Kojima T, Takeda N, Nakagawa T, TaniguchiH, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, KatoT, Okuda J, Ida K. The metabolic syndrome as a predictor ofnonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-728[PMID: 16287793]. 被引量:1

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部